Topic: COVAXIN Vaccine
Australia recognises India’s Covaxin
Australian Government has recognised Covaxin covid-19 vaccine of India on November 1, 2021. Highlights In India, Covaxin and Covishield are the two widely used vaccines. Australia had recognised... WHO seeks clarifications from Bharat Biotech on Covaxin
According to World Health Organisation (WHO), additional clarifications from manufacturer are required to conduct final Emergency Use Listing (EUL) risk-benefit assessment for using Bharat Biotech’s Covaxin globally. Key... Covaxin approved for emergency use in 2–18-year-olds
The Subject Expert Committee on Covid-19 has approved the “emergency use” of Bharat Biotech’s Covaxin vaccine for children aged between 2-18 years old. Key Points Phase-2 and Phase-3...
WHO Chief Scientist: Covid vaccination is not absolute protection
Chief scientist of World Health Organisation (WHO), Dr. Soumya Swaminathan, noted that though Covid-19 vaccines may not provide absolute protection against emerging variants of the coronavirus. However, it... COVAXIN trial starts on children
Trial of COVAXIN, a COVID-19 vaccine by Bharat Biotech, on children below 18 years was started at All India Institute of Medical Sciences (AIIMS), Patna. Background Trail was...
Govt to support Public Sector Companies for Vaccine Production
Union Government has decided to support some public sector companies with grants under the Mission COVID Suraksha to boost covid-19 vaccine production. Key Points Among the companies, one...
PM Takes First Dose of COVID-19 Vaccine
The Prime Minister of India, Narendra Modi, takes first dose of COVID-19 vaccine on March 1, 2021 at AIIMS, New Delhi. After vaccination, he appealed to those people...
SII’s Covishield gets emergency-use nod from DGCI
The Subject Expert committee that is advising the Drug Controller General of India (DCGI) recommended restricted Emergency Use Authorisation for COVISHIELD. COVISHIELD vaccine was developed by Serum Institute...
COVAXIN of Bharat Biotech enters Phase III trials: Largest COVID-19 clinical trial of India
On November 16, 2020 the Bharat Biotech announced the commencement of Phase III trials of COVAXIN vaccines in India. The trials will involve 26,000 volunteers. It is to...
